2. 学历类
  3. Text 3 In 2010,a federal judge shook Ame

Text 3 In 2010,a federal judge shook Ame

admin2022-08-02  45
问题 Text 3 In 2010,a federal judge shook America's biotech industry to its core.Companies had won patents for isolated DNA for decades—by 2005 some 20%of human genes were patented.But in March 2012 a judge ruled that genes were unpatentable.Executives were violently agitated.The Biotechnology Industry Organization（BIO）,a trade group,assured members that this was just a“preliminary step”in a longer battle.On July 29th they were relieved,at least temporarily.A federal appeals court overturned the prior decision,ruling that Myriad Genetics could indeed hold patents to two genes that help forecast a woman's risk of breast cancer.The chief executive of Myriad,a company in Utah,said the ruling was a blessing to firms and patients alike.But as companies continue their attempts at personalized medicine,the courts will remain rather busy.The Myriad case itself is probably not over.Critics make three main arguments against gene patents:a gene is a product of nature,so it may not be patented;gene patents suppress innovation rather than reward it;and patents’monopolies restrict access to genetic tests such as Myriad's.A growing number seem to agree.Last year a federal taskforce urged reform for patents related to genetic tests.In October the Department of Justice filed a brief in the Myriad case,arguing that an isolated DNA molecule“is no less a product of nature…than are cotton fibres that have been separated from cotton seeds.”Despite the appeals court's decision,big questions remain unanswered.For example,it is unclear whether the sequencing of a whole genome violates the patents of individual genes within it.The case may yet reach the Supreme Court.As the industry advances,however,other suits may have an even greater impact.Companies are unlikely to file many more patents for human DNA molecules—most are unlikely patented or in the public domain.Firms are now studying how genes interact,looking for correlations that might be used to determine the causes of disease or predict a drug's efficacy.Companies are eager to win patents for“connecting the dots，”explains Hans Sauer,a lawyers for the BIO.Their success may be determined by a suit related to this issue,brought by the Mayo Clinic,which the Supreme Court will hear in its next term.The BIO recently held a convention which included sessions to coach lawyers on the shifting landscape for patents.Each meeting was packed.By saying“Each meeting was packed”（Line 4，Para.6）,the author means that_____A.the supreme court was authoritativeB.the BIO was a powerful organizationC.gene patenting was a great concernD.lawyers were keen to attend conventions
选项 A.the supreme court was authoritative
B.the BIO was a powerful organization
C.gene patenting was a great concern
D.lawyers were keen to attend conventions
答案 C
解析 含义题【命题思路】这是一道句意理解题，需要根据句子的上下文找到解题的线索，从而得出答案。【直击答案】文章最后一段提到：BIO最近要召开的一个会议，该会议包括指导律师们处理目前的专利问题。紧接着谈到“Each meeting was packed”，这句话中的“packed”的原义为“打包，包装”，而在此句中的意思是“挤满，塞满”，即会议挤满了人。从而反映了大家对基因专利的关注。再从全文的角度来看，本文都是围绕基因专利的问题展开，故正确答案为C项。【干扰排除】A项属于无中生有，末段第一句提到了高级法院将会在下一轮听证这个案件，并未提及高级法院很有权威。B项属于主观臆断，原文提及该组织将会举行会议指导律师处理专利问题，并没有对该组织进行任何评论。D项以偏概全，训练律师只是这次大会的一部分内容，并没有谈及律师是否热衷于参加会议。
转载请注明原文地址:https://www.tihaiku.com/xueli/2699884.html
本试题收录于： 英语二研究生题库研究生入学分类

英语二研究生

研究生入学

相关试题推荐
随机试题
最新回复(0)